Soltis Investment Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
VCM
VPM
Soltis Investment Advisors's AMGN Position: Q1 2026 in Review
Soltis Investment Advisors increased its Amgen (AMGN) stake by 5% in Q1 2026, buying an estimated $465K and bringing the position to 27,252 shares worth $9.59M. The position accounts for 0.6% of the portfolio, ranked #36.
Soltis Investment Advisors first reported a position in AMGN in Q4 2020 and has held it in 21 quarters since. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Soltis Investment Advisors held 27,252 shares of Amgen worth $9.59M as of Q1 2026.
- Soltis Investment Advisors bought 1,303 Amgen shares in Q1 2026, an estimated $465K.
- Amgen made up 0.6% of Soltis Investment Advisors's portfolio in Q1 2026, its #36 holding.
- Soltis Investment Advisors first reported a position in Amgen in Q4 2020 and has held it in 21 quarters since.
- 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Soltis Investment Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.